Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial. Penson DF, Armstrong AJ, Concepcion R, Agarwal N, Olsson C, Karsh L, Dunshee C, Wang F, Wu K, Krivoshik A, Phung D, Higano CS (2016) J Clin Oncol 34: 2098-106 Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia. Moslehi JJ, Deininger M (2015) J Clin Oncol 33: 4210-8 Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. Rimawi MF, Mayer IA, Forero A, Nanda R, Goetz MP, Rodriguez AA, Pavlick AC, Wang T, Hilsenbeck SG, Gutierrez C, Schiff R, Osborne CK, Chang JC (2013) J Clin Oncol 31: 1726-31 Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Mayer IA, Abramson VG, Isakoff SJ, Forero A, Balko JM, Kuba MG, Sanders ME, Yap JT, Van den Abbeele AD, Li Y, Cantley LC, Winer E, Arteaga CL (2014) J Clin Oncol 32: 1202-9 Urological cancer: walking the tightrope of survival and quality of life with ADT. Resnick MJ (2013) Nat Rev Clin Oncol 10: 307-8 Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA (2012) J Natl Cancer Inst 104: 1264; author reply 1266-8 Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies. Xu L, Korade Z, Porter NA (2010) J Am Chem Soc 132: 2222-32 Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL (2000) Proc Natl Acad Sci U S A 97: 9609-14 Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. Zhang G, Kernan KA, Collins SJ, Cai X, López-Guisa JM, Degen JL, Shvil Y, Eddy AA (2007) J Am Soc Nephrol 18: 846-59 Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, Arteaga CL (2000) Cancer Res 60: 5887-94 Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells. Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ (2003) Cancer Res 63: 616-20 Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog. Edgerton DS, Johnson KM, Neal DW, Scott M, Hobbs CH, Zhang X, Duttaroy A, Cherrington AD (2009) Diabetes 58: 243-9 A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer. Mayer IA, Abramson VG, Formisano L, Balko JM, Estrada MV, Sanders ME, Juric D, Solit D, Berger MF, Won HH, Li Y, Cantley LC, Winer E, Arteaga CL (2017) Clin Cancer Res 23: 26-34 A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Miller TW, Balko JM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, González-Angulo AM, Mills GB, Miller WR, Wu H, Shyr Y, Arteaga CL (2011) Clin Cancer Res 17: 2024-34 ErbB receptor signaling and therapeutic resistance to aromatase inhibitors. Shin I, Miller T, Arteaga CL (2006) Clin Cancer Res 12: 1008s-1012s Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression. Jin R, Yamashita H, Yu X, Wang J, Franco OE, Wang Y, Hayward SW, Matusik RJ (2015) Oncogene 34: 3700-10 Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA (2009) Hypertension 54: 516-23 Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Chen X, Austin ED, Talati M, Fessel JP, Farber-Eger EH, Brittain EL, Hemnes AR, Loyd JE, West J (2017) Eur Respir J 50: Radiation Dosimetry of (18)F-FPEB in Humans. Kessler RM, Seibyl J, Cowan RL, Zald D, Young JS, Ansari MS, Stabin MG (2014) J Nucl Med 55: 1119-21 Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification. Balko JM, Mayer IA, Sanders ME, Miller TW, Kuba MG, Meszoely IM, Wagle N, Garraway LA, Arteaga CL (2012) Mol Cancer Ther 11: 2301-5 Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E (2004) J Virol 78: 4108-19 Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. Arteaga CL, Ramsey TT, Shawver LK, Guyer CA (1997) J Biol Chem 272: 23247-54 Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. Watanabe H, de Caestecker MP, Yamada Y (2001) J Biol Chem 276: 14466-73 Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL (2004) J Biol Chem 279: 24505-13 Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation. Martin KA, Schalm SS, Romanelli A, Keon KL, Blenis J (2001) J Biol Chem 276: 7892-8 Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606. Oliver KH, Jessen T, Crawford EL, Chung CY, Sutcliffe JS, Carneiro AM (2014) Mol Pharmacol 85: 921-31 Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Andrieux L, Langouët S, Fautrel A, Ezan F, Krauser JA, Savouret JF, Guengerich FP, Baffet G, Guillouzo A (2004) Mol Pharmacol 65: 934-43 Androgen receptor-mediated repression of novel target genes. Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA (2007) Prostate 67: 1371-83 Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Zeng H, Waldman WJ, Yin DP, Knight DA, Shen J, Ma L, Meister GT, Chong AS, Williams JW (2005) Transplantation 79: 17-22 Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening. Dahlman KB, Parker JS, Shamu T, Hieronymus H, Chapinski C, Carver B, Chang K, Hannon GJ, Sawyers CL (2012) PLoS One 7: e34414 The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer. Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M (2005) J Urol 174: 547-52; discussion 552 Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Seth A, Yan F, Polk DB, Rao RK (2008) Am J Physiol Gastrointest Liver Physiol 294: G1060-9 Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. Park GY, Joo M, Pedchenko T, Blackwell TS, Christman JW (2004) Am J Physiol Lung Cell Mol Physiol 286: L956-62 Cooperativity of cytochrome P450 1A2: interactions of 1,4-phenylene diisocyanide and 1-isopropoxy-4-nitrobenzene. Isin EM, Sohl CD, Eoff RL, Guengerich FP (2008) Arch Biochem Biophys 473: 69-75 MEK and EGFR inhibition demonstrate synergistic activity in EGFR-dependent NSCLC. Balko JM, Jones BR, Coakley VL, Black EP (2009) Cancer Biol Ther 8: 522-30 Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer. Lloyd A, Penson D, Dewilde S, Kleinman L (2008) Prostate Cancer Prostatic Dis 11: 153-9 Characterization of stable human aromatase expressed in E. coli. Kagawa N, Hori H, Waterman MR, Yoshioka S (2004) Steroids 69: 235-43 Dysregulation of E-cadherin by oncogenic Ras in intestinal epithelial cells is blocked by inhibiting MAP kinase. Schmidt CR, Washington MK, Gi YJ, Coffey RJ, Beauchamp RD, Pearson AS (2003) Am J Surg 186: 426-30 Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide? Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M, Penson D (2005) Urology 66: 835-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.